Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: Results from the fifth korea national health and nutrition examination survey, 2010–2011

Endocrine Journal

Volumn 62, Issue 7, 2015, Pages 585-592

  Hong, Namki ^a   Lee, Eun Young ^a   Kim, Chang Oh ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Gamma glutamyl transferase; Insulin resistance; Obesity; Sarcopenia

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BODY MASS; COMMUNITY LIVING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HEALTH SURVEY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL HEALTH; PREVALENCE; SARCOPENIA; SARCOPENIC OBESITY; WAIST CIRCUMFERENCE; AGED; BLOOD; BODY COMPOSITION; COMPLICATION; CROSS-SECTIONAL STUDY; MIDDLE AGED; NUTRITION; OBESITY; SOUTH KOREA;

AGED; BODY COMPOSITION; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; REPUBLIC OF KOREA; SARCOPENIA; WAIST CIRCUMFERENCE;

EID: 84938386750     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0119     Document Type: Article

References (32)

1. Evans WJ (1995) What is sarcopenia? J Gerontol A Biol Sci Med Sci 50 Spec No: 5-8.
2. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50: 889-896.
3. Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ (2014) Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr 68: 1001-1007.
4. Kim JH, Lim S, Choi SH, Kim KM, Yoon JW, et al. (2014) Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men. J Gerontol A Biol Sci Med Sci 69: 1244-1252.
5. Roubenoff R (2000) Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci 904: 553-557.
6. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, et al. (2005) Sarcopenia, obe sity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr 82: 428-434.
7. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, et al. (2010) Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 33: 1652-1654.
8. Batsis JA, Barre LK, Mackenzie TA, Pratt SI, Lopez- Jimenez F, et al. (2013) Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc 61: 974-980.
9. Kim YS, Lee Y, Chung YS, Lee DJ, Joo NS, et al. (2012) Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 67: 1107-1113.
10. Christensen K, Doblhammer G, Rau R, Vaupel JW (2009) Ageing populations: the challenges ahead. Lancet 374: 1196-1208.
11. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, et al. (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39: 412-423.
12. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52: 80-85.
13. Kunutsor SK, Abbasi A, Adler AI (2014) Gammaglutamyl transferase and risk of type II diabetes: an updated systematic review and dose-response metaanalysis. Ann Epidemiol 24: 809-816.
14. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, et al. (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27: 127-133.
15. Whitfield JB (2001) Gamma glutamyl transferase. Crit Rev Clin Lab Sci 38: 263-355.
16. Akehi Y, Tsutsumi Y, Tatsumoto A, Yoshida R, Ohkubo K, et al. (2010) Serum gamma-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men. Endocr J 57: 981- 989.
17. Bradley RD, Fitzpatrick AL, Jacobs DR,, Lee DH, Swords Jenny N, et al. (2014) Associations between gamma-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis 233: 387-393.
18. Moon SS (2014) Low skeletal muscle mass is associ ated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J 61: 61-70.
19. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, et al. (2007) Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75: 72-80.
20. Persijn JP, van der Slik W (1976) A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem 14: 421-427.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
22. Park H, Kim K (2012) Relationship between alcohol consumption and serum lipid levels in elderly Korean men. Arch Gerontol Geriatr 55: 226-230.
23. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, et al. (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35: 1381-1395.
24. Waters DL, Baumgartner RN (2011) Sarcopenia and obesity. Clin Geriatr Med 27: 401-421.
25. Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR, Jr. (2007) A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 53: 1092- 1098.
26. Zoppini G, Targher G, Trombetta M, Lippi G, Muggeo M (2009) Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes. Obesity (Silver Spring) 17: 370-374.
27. Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, et al. (2014) Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology 59: 1772-1778.
28. Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346: 1221-1231.
29. Moylan JS, Reid MB (2007) Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35:411-429.
30. Examination Committee of Criteria for ‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66: 987-992.
31. Oh SW (2011) Obesity and metabolic syndrome in Korea. Diabetes Metab J 35: 561-566.
32. Chen Z, Han CK, Pan LL, Zhang HJ, Ma ZM, et al. (2014) Serum alanine aminotransferase independently correlates with intrahepatic triglyceride contents in obese subjects. Dig Dis Sci 59: 2470-2476.